Jazz Pharmaceuticals SVP Mary Elizabeth Henderson Disposes of 2,092 Shares for Tax Withholding

Executive Summary

On September 2, 2026, Mary Elizabeth Henderson, Senior Vice President of Technical Operations at Jazz Pharmaceuticals plc ($JAZZ), reported dispositions totaling 2,092 ordinary shares on August 31, 2026. The total transaction value was approximately $505,040. Following these transactions, Henderson directly retains 25,242 ordinary shares.

Transaction Breakdown

• Transaction 1: 2,076 shares disposed of at $241.39 per share.
• Transaction 2: 16 shares disposed of at $244.6444 per share.
• Transaction Code: 'F' (Payment of exercise price or tax liability by delivering or withholding securities).
• Nature: Shares were automatically withheld/sold to cover tax liabilities arising from the vesting of previously granted restricted stock units (RSUs).

Market Impact & Significance

This disposition is categorized as Low Significance from an investment perspective. Transactions coded 'F' are standard, non-discretionary actions taken to satisfy statutory tax withholding requirements upon equity vesting, rather than open-market discretionary selling driven by market outlook or sentiment.